Covered recipient · General Payments record
JOHN GRAFF
Allopathic & Osteopathic Physicians Urology
General Payments · PY2021–2024
$2,577.17
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,465.94 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| COLOPLAST CORP | $1,136.48 | 9 |
| BOSTON SCIENTIFIC CORPORATION | $159.83 | 2 |
| TOLMAR, INC. | $54.40 | 2 |
| PFIZER INC. | $36.76 | 2 |
| Dendreon Pharmaceuticals LLC | $33.38 | 1 |
| ABBVIE INC. | $26.52 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.52 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103827568 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.57 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086242110 | CMS |
| Boston Scientific Corporation | $81.42 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092501748 | CMS |
| Boston Scientific Corporation | $78.41 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092501746 | CMS |
| COLOPLAST CORP | $220.28 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464838 | CMS |
| COLOPLAST CORP | $152.66 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464818 | CMS |
| COLOPLAST CORP | $151.08 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464834 | CMS |
| COLOPLAST CORP | $4.40 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464836 | CMS |
| COLOPLAST CORP | $17.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464820 | CMS |
| COLOPLAST CORP | $151.80 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464822 | CMS |
| COLOPLAST CORP | $139.83 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464858 | CMS |
| COLOPLAST CORP | $176.44 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464856 | CMS |
| COLOPLAST CORP | $122.42 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117464872 | CMS |
| Dendreon Pharmaceuticals LLC | $33.38 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149316424 | CMS |
| PFIZER INC. | $21.24 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131500056 | CMS |
| PFIZER INC. | $15.52 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131514761 | CMS |
| Tolmar, Inc. | $29.31 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138703717 | CMS |
| Tolmar, Inc. | $25.09 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138703719 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.